跳轉至內容
Merck
全部照片(1)

重要文件

57857

Sigma-Aldrich

Lithium iodoacetate

≥97.0% (NT)

同義詞:

碘乙酸 锂盐

登入查看組織和合約定價


About This Item

線性公式:
ICH2COOLi
CAS號碼:
分子量::
191.88
Beilstein:
4208524
EC號碼:
MDL號碼:
分類程式碼代碼:
12352103
PubChem物質ID:
NACRES:
NA.25

等級

for analytical purposes

品質等級

化驗

≥97.0% (NT)

雜質

≤3% water

mp

239 °C (dec.) (lit.)
~245 °C (dec.)

SMILES 字串

[Li+].[O-]C(=O)CI

InChI

1S/C2H3IO2.Li/c3-1-2(4)5;/h1H2,(H,4,5);/q;+1/p-1

InChI 密鑰

RZCFQIDTJPHHFJ-UHFFFAOYSA-M

尋找類似的產品? 前往 產品比較指南

應用

Lithium iodoacetate, a halogenacetate, is a lithium salt of iodoacetate that may be used in the study of cysteine peptidases.

注意

May discolor to yellow on storage

其他說明

Sales restrictions may apply

象形圖

Exclamation mark

訊號詞

Warning

危險分類

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

標靶器官

Respiratory system

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

未看到正確版本?

如果您需要一個特定的版本,您可以透過批號來尋找特定憑證。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Ehrenberg et al.
Acta crystallographica. Section B, Structural science, 55(Pt 4), 517-524 (2000-08-06)
Most halogenoacetates of alkali salts readily undergo a thermally induced polymerization reaction to poly-(hydroxyacetic acid) in the solid state. The lithium salts represent a remarkable exception. The crystal structures of lithium chloroacetate, lithium bromoacetate and lithium iodoacetate were determined ab
Yun Ju Woo et al.
Experimental & molecular medicine, 43(10), 561-570 (2011-07-29)
Osteoarthritis (OA) is an age-related joint disease that is characterized by degeneration of articular cartilage and chronic pain. Oxidative stress is considered one of the pathophysiological factors in the progression of OA. We investigated the effects of grape seed proanthocyanidin
Sébastien Goutal et al.
Drug delivery and translational research, 8(3), 536-542 (2018-01-03)
Elacridar (GF120918) is a highly potent inhibitor of both P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2), the main efflux transporters expressed at the blood-brain barrier (BBB). Elacridar shows very low aqueous solubility, which complicates its formulation for i.v. administration.
Sébastien Goutal et al.
Journal of pharmaceutical and biomedical analysis, 123, 173-178 (2016-02-26)
In clinical practice, rifampicin exposure is estimated from its concentration in venous blood samples. In this study, we hypothesized that differences in rifampicin concentration may exist between arterial and venous plasma. An HPLC-UV method for determining rifampicin concentration in plasma
Runqiang Yang et al.
Journal of the science of food and agriculture, 91(13), 2437-2442 (2011-06-28)
Proteases have become an essential part of the modern food and feed industry, being incorporated in a large and diversified range of products for human and animal consumption. The objective of this study was to purify and characterise a protease

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務